Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma

Stephan M Tirier, PhD, Jan-Philipp Mallm, PhD, Nicola Casiraghi, PhD, Hana Susak, PhD, Nicola Giesen, MD, Alexandra M Poos, PhD, Katharina Bauer, Anja Baumann, Lukas John, MD, Jing Xu, PhD, Lara Klett, MSc, Carsten Müller-Tidow, MD, Benedikt Brors, PhD, Hartmut Goldschmidt, MD, Niels Weinhold, PhD, Oliver Stegle, PhD, Karsten Rippe, PhD, Marc S. Raab, MD

Blood (2019) 134 (Supplement_1): 571.

https://doi.org/10.1182/blood-2019-128625

Published: 2019

Journal Articles

RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition

Ethel Cesarman, MD PhD, Mikhail Roshal, MD PhD, Jonathan Reichel, PhD, Wagner Florian, PhD, Bhavneet Binder, Sakellarios Zairis, Jouliana Sadek, PhD, Joshua Brody, MD, Raul Rabadan, PhD, Sandeep Dave, MD

Blood (2019) 134 (Supplement_1): 549.

https://doi.org/10.1182/blood-2019-131163

Published: 2019

Journal Articles

Deep DNA Sequencing Identifies Small Mutations in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Analysis of Intratumor Genomic Heterogeneity for Prediction of Disease Relapse

Athena Kritharis, MD, Sukhdeep Kaur, MD, Jui Wan Loh, BS, Mohammad Hadigol, PhD, Hossein Khiabanian, PhD, Roger Strair, MD PhD

Blood (2019) 134 (Supplement_1): 1445.

https://doi.org/10.1182/blood-2019-126303

Published: 2019

Journal Articles

Single Cell Approaches - Drilling Down Deeper Using Technology and Integrated Data Analyses

Dan A. Landau, MD

Blood (2019) 134 (Supplement_1): SCI-28.

https://doi.org/10.1182/blood-2019-121046

Published: 2019

Journal Articles

Oncolytic Virus Therapy with HSV-1 for Hematologic Malignancies

Ryo Ishino, Yumi Kawase, MD, Toshio Kitawaki, MD PhD, Naoshi Sugimoto, MD PhD, Maki Oku, MD, Shumpei Uchida, MD, Osamu Imataki, MD PhD, Akihito Matsuoka, MD PhD, Teruhisa Taoka, MD PhD, Kimihiro Kawakami, MD PhD, Tomoki Todo, MD PhD, Akifumi Takaori-Kondo, MD PhD, Norimitsu Kadowaki, MD PhD

Blood (2019) 134 (Supplement_1): 3242.

https://doi.org/10.1182/blood-2019-127754

Published: 2019

Journal Articles

Inhibition of platelet GPVI induces intratumor hemorrhage and increases efficacy of chemotherapy in mice

Julia Volz, Elmina Mammadova-Bach, Jesus Gil-Pulido, Rajender Nandigama, Katharina Remer, Lydia Sorokin, Alma Zernecke, Scott I. Abrams, Süleyman Ergün, Erik Henke, Bernhard Nieswandt

Blood (2019) 133 (25): 2696–2706.

https://doi.org/10.1182/blood.2018877043

Published: 2019

Includes: Supplemental data

Journal Articles

The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma

Blood (2018) 132 (1): 59–66.

https://doi.org/10.1182/blood-2018-04-842880

Published: 2018

Includes: Supplemental data

Journal Articles

Next-Generation Functional Drug Screening for Patients with Aggressive Hematologic Malignancies

Blood (2017) 130 (Supplement 1): 855.

https://doi.org/10.1182/blood.V130.Suppl_1.855.855

Published: 2017

Journal Articles

AICDA Introduces Epigenetic Plasticity in Germinal Center-Derived Lymphomas and Accelerates Lymphomagenesis

Maria Del Pilar Dominguez, PhD, Matt Teater, M.S., David Redmond, Zhengming Cheng, PhD, Jayanta Chaudhuri, PhD, Olivier Elemento, PhD, Ari Melnick, MD, Rita Shaknovich, MD PhD

Blood (2016) 128 (22): 1045.

https://doi.org/10.1182/blood.V128.22.1045.1045

Published: 2016

Journal Articles

Single-Cell Analysis of Clonal Dynamics in Childhood ALL Reveals a Key Role for Transcriptional Intratumor Heterogeneity in Driving Resistance to Chemotherapy

Virginia A Turati, PhD, José Afonso Guerra-Assunção, PhD, John C Ambrose, PhD, John Brown, PhD, Mike Hubank, PhD, Alex Hobbs, PhD, Mark Lynch, PhD, Bernadett Gaal, PhD, Sarah Inglott, Lucia Conde, PhD, Simon Richardson, MD PhD, Javier Herrero, PhD, Sten Eirik Jacobsen, MD PhD, Tariq Enver, PhD

Blood (2016) 128 (22): 606.

https://doi.org/10.1182/blood.V128.22.606.606

Published: 2016

Journal Articles

Intratumoral Administration of the Immunotherapeutic Combination Anti-ctla4, Anti-cd137 and Anti-ox40: Comparison to Systemic Administration, Peri-Draining Lymph Node Injection, and Cellular Vaccine in a Mouse Lymphoma Model

Jonathan P. O. Hebb, FRCPC, MD MSC, Adriane Mosley, BSc, Felipe Vences Catalan, Peter Ellmark, Per Norlen, Dean W Felsher, MD PhD

Blood (2016) 128 (22): 4172.

https://doi.org/10.1182/blood.V128.22.4172.4172

Published: 2016

Journal Articles

A Multicenter Phase II Study of Sequential Administration of Unmanipulated DLI and Donor Derived Cytokine Induced Killer (CIK) Cells in HSCT Patients, Relapsed of Disease

Martino Introna, MD, Elisa Gotti, BA, Michela Bonzi, BA, Josee Golay, PhDBA, Alessandra Algarotti, MD, Caterina Micò, MD, Anna Grassi, MD, Cristina Boschini, Maria Luisa Ferrari, BSc, Irene Cavattoni, MD, Ettore Biagi, MD, Adriana Balduzzi, Sr., MD, Attilio Rovelli, MD, Paolo Perseghin, MD, Giuseppe Gaipa, PhD, Andrea Biondi, Alessandro Rambaldi, MD

Blood (2015) 126 (23): 3160.

https://doi.org/10.1182/blood.V126.23.3160.3160

Published: 2015

Journal Articles

Systemic Antitumor Effects of Intratumoral Administration of the Novel Immunotherapeutic Combination Anti-CTLA4, Anti-CD137, and Anti-OX40 in Mouse Models of Lymphoma and Solid Tumor

Hebb Jonathan, MD MSc, Holbrook E Kohrt, MD PhD

Blood (2015) 126 (23): 1552.

https://doi.org/10.1182/blood.V126.23.1552.1552

Published: 2015

Journal Articles

Mir-29a Displays in Vitro and in Vivo Anti-Tumor Activity in Multiple Myeloma

Manujendra N Saha, PhD, Yan Chen, Jahangir Abdi, PhD, Hong Chang

Blood (2014) 124 (21): 2090.

https://doi.org/10.1182/blood.V124.21.2090.2090

Published: 2014

Journal Articles

Combination Immunotherapy of Advanced Lymphoma with Oncolytic Vaccinia Virus and Checkpoint Inhibitor Following Local Tumor Irradiation

Boris Minev, MD, Holbrook Kohrt, MD, Mehmet Kilinc, PhD, Nanhai Chen, PhD, Audrey Feng, Maysam Pessian, Ulrike Geissinger, Erik Haefner, Desislava Tsoneva, Kliment Bozhilov, Idit Sagiv Barfi, PhD, Xing Zhao, Narendiran Rajasekaran, PhDMSc, Ronald Levy, MD, Aladar Szalay, PhD

Blood (2014) 124 (21): 4487.

https://doi.org/10.1182/blood.V124.21.4487.4487

Published: 2014

Journal Articles

Turning a Tumor into a Vaccine Factory: In Situ Vaccination for Low-Grade Lymphoma

Thomas Marron, MD PhD, Nina Bhardwaj, MD PhD, Elizabeth Crowley, Tibor Keler, PhD, Thomas A. Davis, MD, Joshua Brody, MD

Blood (2014) 124 (21): 5473.

https://doi.org/10.1182/blood.V124.21.5473.5473

Published: 2014

Journal Articles

Platelet Depletion Reduces Tumor Hypoxia and Metastasis Mediated by Met Signaling Pathway

Rong Li, Meiping Ren, Ni Chen, Mao Luo, Jianbo Wu

Blood (2012) 120 (21): 3321.

https://doi.org/10.1182/blood.V120.21.3321.3321

Published: 2012

Journal Articles

Suppressing Immunosuppressive Pathways by RNA Interference Synergizes with Tumor Antigen Vaccines Causing Long-Term Regression of Established Subcutaneous Lymphomas

Edwin R Manuel, Ph.D., Celine Blache, Ph.D., Teodora Kaltcheva, PhD, Fernanda Castro, Ph.D., Don J. Diamond, PhD

Blood (2011) 118 (21): 106.

https://doi.org/10.1182/blood.V118.21.106.106

Published: 2011

Journal Articles

Ad-ISF35 Intratumoral Administration Induces a Bystander Effect and Immune-Mediated Tumor Rejection with a Safe Vector Biodistribution and Toxicology Profile In a NHL Mouse Model.

Johanna Melo-Cardenas, B.Sc, Mauricio Urquiza, PhD, Robier Aguillon-Prada, M.D, Thomas J. Kipps, MD, PhD, Januario E Castro, M.D

Blood (2010) 116 (21): 1470.

https://doi.org/10.1182/blood.V116.21.1470.1470

Published: 2010

Journal Articles

Analysis of Platelets in Solid Tumor Patients: Profound Changes and Unexpected Findings.

Tina Wiesner, Stefanie Bugl, Joerg T Hartmann, Lothar Kanz, Hans-Georg Kopp

Blood (2009) 114 (22): 4012.

https://doi.org/10.1182/blood.V114.22.4012.4012

Published: 2009

NARROW

Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma

RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition

Deep DNA Sequencing Identifies Small Mutations in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Analysis of Intratumor Genomic Heterogeneity for Prediction of Disease Relapse

Single Cell Approaches - Drilling Down Deeper Using Technology and Integrated Data Analyses

Oncolytic Virus Therapy with HSV-1 for Hematologic Malignancies

Inhibition of platelet GPVI induces intratumor hemorrhage and increases efficacy of chemotherapy in mice

The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma

Next-Generation Functional Drug Screening for Patients with Aggressive Hematologic Malignancies

AICDA Introduces Epigenetic Plasticity in Germinal Center-Derived Lymphomas and Accelerates Lymphomagenesis

Single-Cell Analysis of Clonal Dynamics in Childhood ALL Reveals a Key Role for Transcriptional Intratumor Heterogeneity in Driving Resistance to Chemotherapy

Intratumoral Administration of the Immunotherapeutic Combination Anti-ctla4, Anti-cd137 and Anti-ox40: Comparison to Systemic Administration, Peri-Draining Lymph Node Injection, and Cellular Vaccine in a Mouse Lymphoma Model

A Multicenter Phase II Study of Sequential Administration of Unmanipulated DLI and Donor Derived Cytokine Induced Killer (CIK) Cells in HSCT Patients, Relapsed of Disease

Systemic Antitumor Effects of Intratumoral Administration of the Novel Immunotherapeutic Combination Anti-CTLA4, Anti-CD137, and Anti-OX40 in Mouse Models of Lymphoma and Solid Tumor

Mir-29a Displays in Vitro and in Vivo Anti-Tumor Activity in Multiple Myeloma

Combination Immunotherapy of Advanced Lymphoma with Oncolytic Vaccinia Virus and Checkpoint Inhibitor Following Local Tumor Irradiation

Turning a Tumor into a Vaccine Factory: In Situ Vaccination for Low-Grade Lymphoma

Platelet Depletion Reduces Tumor Hypoxia and Metastasis Mediated by Met Signaling Pathway

Suppressing Immunosuppressive Pathways by RNA Interference Synergizes with Tumor Antigen Vaccines Causing Long-Term Regression of Established Subcutaneous Lymphomas

Ad-ISF35 Intratumoral Administration Induces a Bystander Effect and Immune-Mediated Tumor Rejection with a Safe Vector Biodistribution and Toxicology Profile In a NHL Mouse Model.

Analysis of Platelets in Solid Tumor Patients: Profound Changes and Unexpected Findings.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only